Taro Pharmaceutical Industries Ltd.: meeting of 22 May 2024

Votes reported on Form N-PX, item by item

60 Form N-PX filers reported votes at the Taro Pharmaceutical Industries Ltd. meeting of 22 May 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

100 vote records from 54 filers. 3 of the 50 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.

87.0% for5.6% against7.4% other6.0% against management54 filers76.4% for22.6% against1.0% other23.1% against management968,606 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

20 vote records from 11 filers. 0 of the 4 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

81.8% for0.0% against18.2% other0.0% against management11 filers100.0% for0.0% against0.0% against management460,899 reported shares, counted once per item in this group

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

81 vote records from 43 filers. No filer marked a management recommendation, so no against-management figure is reported. 43 filers reported this item without a management mark.

90.7% for0.0% against9.3% other43 filers98.8% for0.0% against1.2% other488,441 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Taro Pharmaceutical Industries Ltd. meeting?

60 Form N-PX filers reported votes at the meeting of 22 May 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Taro Pharmaceutical Industries Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Taro Pharmaceutical Industries Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Taro Pharmaceutical Industries Ltd. with a meeting date within three days of 22 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.